Vestor Capital’s Novartis NVS Stock Holding History

Vestor Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-558	Closed	-$56K	–	273
2023 Q2	$56K	Buy	+558	New	+$55.8K	0.01%	234

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vestor Capital's NVS Position: Q3 2023 in Review

Vestor Capital sold out of Novartis (NVS) in Q3 2023, closing a stake of 558 shares — an estimated $56K sold.

Vestor Capital first reported a position in NVS in Q2 2023 and held it in 1 quarter. The position peaked at $56K in Q2 2023. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Vestor Capital reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
Vestor Capital sold 558 Novartis shares in Q3 2023, an estimated $56K.
Vestor Capital first reported a position in Novartis in Q2 2023 and held it in 1 quarter.
Vestor Capital's Novartis position peaked at $56K in Q2 2023.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Vestor Capital's 13F filing for Q3 2023, filed 8 Nov 2023.